Alector, Inc. (ALEC) stock

ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3069% below fair value

$2.54+0.09 (+3.67%)

Close on Nov 13, 2026Market cap $283.61MP/E 7.3Yield –

Alector EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Alector's EV/EBITDA was 0.9× on Aug 31, 2022.

Period	Period end	Value	Change (pts)
2022	Aug 31, 2022	0.9×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ALEC.

Revenue growth151.2% · median 18.7%

Operating margin20.2% · median -160.1%

Net margin23.9% · median -208.6%

Advertisement
300 × 250

See a number that looks wrong?